Wednesday, September 2, 2015

British Journal of Cancer - Table of Contents alert Volume 113 Issue 5

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 113, Issue 5 (693-860)
Published online 1 September 2015

In this issue
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
The British Journal of Cancer presents four special Web Focuses in key areas of interest. Click on the links below to access each focus for free. 

Web Focus on Systemic Inflammation as a Prognostic Marker in Cancer 

Web Focus on Melanoma, the Great Leap Forward

Web Focus on New Drugs to Watch  

Web Focus on The Changing Landscape of Breast Cancer Prognostic Prediction 
 

Minireview

Top

Hitting the brakes: targeting microtubule motors in cancer

Gayathri Chandrasekaran, Péter Tátrai and Fanni Gergely

Br J Cancer 2015 113: 693-698; advance online publication, July 16, 2015; 10.1038/bjc.2015.264

Abstract | Full Text

Clinical Studies

Top

A Bayesian adaptive design for biomarker trials with linked treatments

James M S Wason, Jean E Abraham, Richard D Baird, Ioannis Gournaris, Anne-Laure Vallier, James D Brenton, Helena M Earl and Adrian P Mander

Br J Cancer 2015 113: 699-705; advance online publication, August 11, 2015; 10.1038/bjc.2015.278

Abstract | Full Text

Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours

B Milojkovic Kerklaan, M P J Lolkema, L A Devriese, E E Voest, A Nol-Boekel, M Mergui-Roelvink, M Langenberg, K Mykulowycz, J Stoebenau, S Lane, P Legenne, P Wissel, D A Smith, B J Giantonio, J H M Schellens and P O Witteveen

Br J Cancer 2015 113: 706-715; advance online publication, August 20, 2015; 10.1038/bjc.2015.257

Abstract | Full Text

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)

J Feilchenfeldt, Z Varga, M Siano, H I Grabsch, U Held, B Schuknecht, A Trip, T Hamaguchi, P Gut, O Balague, K Khanfir, J Diebold, W Jochum, H Shoji, R Kushima, D Wagner, Y Shimada, A Cats, A Knuth, H Moch, S Aebi and S Hofer

Br J Cancer 2015 113: 716-721; advance online publication, August 27, 2015; 10.1038/bjc.2015.279

Abstract | Full Text

Translational Therapeutics

Top

TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial

J M S Bartlett, T O Nielsen, D Gao, K A Gelmon, M A Quintayo, J Starczynski, L Han, M J Burnell, M N Levine, B E Chen, L E Shepherd and J W Chapman on behalf of the NCIC CTG4

Br J Cancer 2015 113: 722-728; advance online publication, August 18, 2015; 10.1038/bjc.2015.271

Abstract | Full Text

IGF-IR: a new prognostic biomarker for human glioblastoma

C Maris, N D'Haene, A-L Trépant, M Le Mercier, S Sauvage, J Allard, S Rorive, P Demetter, C Decaestecker and I Salmon

Br J Cancer 2015 113: 729-737; advance online publication, August 20, 2015; 10.1038/bjc.2015.242

Abstract | Full Text

Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro

Wenqing Cao, Jeffrey H Peters, Dylan Nieman, Meenal Sharma, Thomas Watson and JiangZhou Yu

Br J Cancer 2015 113: 738-746; advance online publication, August 11, 2015; 10.1038/bjc.2015.292

Abstract | Full Text

Molecular Diagnostics

Top

CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

J Y Liu, F Li, L P Wang, X F Chen, D Wang, L Cao, Y Ping, S Zhao, B Li, S H Thorne, B Zhang, P Kalinski and Y Zhang

Br J Cancer 2015 113: 747-755; advance online publication, August 18, 2015; 10.1038/bjc.2015.290

Abstract | Full Text

Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma

M Sadeghi, I Lahdou, H Oweira, V Daniel, P Terness, J Schmidt, K-H Weiss, T Longerich, P Schemmer, G Opelz and A Mehrabi

Br J Cancer 2015 113: 756-762; advance online publication, August 13, 2015; 10.1038/bjc.2015.227

Abstract | Full Text

Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis

Y Pan, F Cao, A Guo, W Chang, X Chen, W Ma, X Gao, S Guo, C Fu and J Zhu

Br J Cancer 2015 113: 763-772; advance online publication, July 21, 2015; 10.1038/bjc.2015.260

Abstract | Full Text

MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics

Melanie Di Benedetto, Aurore Toullec, Hélène Buteau-Lozano, Mohamed Abdelkarim, Sophie Vacher, Guillaume Velasco, Monique Christofari, Marc Pocard, Ivan Bieche and Martine Perrot-Applanat

Br J Cancer 2015 113: 773-785; advance online publication, July 21, 2015; 10.1038/bjc.2015.267

Abstract | Full Text

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters

M A Versluis, R A de Jong, A Plat, T Bosse, V T Smit, H Mackay, M Powell, A Leary, L Mileshkin, H C Kitchener, E J Crosbie, R J Edmondson, C L Creutzberg, H Hollema, T Daemen, G H de Bock and H W Nijman

Br J Cancer 2015 113: 786-793; advance online publication, July 28, 2015; 10.1038/bjc.2015.268

Abstract | Full Text

Epidemiology

Top

Long-term subjective cognitive functioning following adjuvant systemic treatment: 7–9 years follow-up of a nationwide cohort of women treated for primary breast cancer

A Amidi, S Christensen, M Mehlsen, A B Jensen, A D Pedersen and R Zachariae

Br J Cancer 2015 113: 794-801; advance online publication, July 14, 2015; 10.1038/bjc.2015.243

Abstract | Full Text

Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors

C E Olsson, D Alsadius, N Pettersson, S L Tucker, U Wilderäng, K-A Johansson and G Steineck

Br J Cancer 2015 113: 802-808; advance online publication, August 4, 2015; 10.1038/bjc.2015.275

Abstract | Full Text

Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort

Mia Hashibe, Carlotta Galeone, Saundra S Buys, Lisa Gren, Paolo Boffetta, Zuo-Feng Zhang and Carlo La Vecchia

Br J Cancer 2015 113: 809-816; advance online publication, August 20, 2015; 10.1038/bjc.2015.276

Abstract | Full Text

Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium

C M Nagle, S C Dixon, A Jensen, S K Kjaer, F Modugno, A deFazio, S Fereday, J Hung, S E Johnatty, Australian Ovarian Cancer Study Group, P A Fasching, M W Beckmann, D Lambrechts, I Vergote, E Van Nieuwenhuysen, S Lambrechts, H A Risch, M A Rossing, J A Doherty, K G Wicklund, J Chang-Claude, M T Goodman, R B Ness, K Moysich, F Heitz, A du Bois, P Harter, I Schwaab, K Matsuo, S Hosono, E L Goode, R A Vierkant, M C Larson, B L Fridley, C Høgdall, J M Schildkraut, R P Weber, D W Cramer, K L Terry, E V Bandera, L Paddock, L Rodriguez-Rodriguez, N Wentzensen, H P Yang, L A Brinton, J Lissowska, E Høgdall, L Lundvall, A Whittemore, V McGuire, W Sieh, J Rothstein, R Sutphen, H Anton-Culver, A Ziogas, C L Pearce, A H Wu and P M Webb for the Ovarian Cancer Association Consortium

Br J Cancer 2015 113: 817-826; advance online publication, July 7, 2015; 10.1038/bjc.2015.245

Abstract | Full Text

Pre-existing diabetes and breast cancer prognosis among elderly women

J Luo, M Hendryx, B Virnig, S Wen, R Chlebowski, C Chen, T Rohan, L Tinker, J Wactawski-Wende, L Lessin and K L Margolis

Br J Cancer 2015 113: 827-832; advance online publication, July 9, 2015; 10.1038/bjc.2015.249

Abstract | Full Text

Understanding cervical screening non-attendance among ethnic minority women in England

L A V Marlow, J Wardle and J Waller

Br J Cancer 2015 113: 833-839; advance online publication, July 14, 2015; 10.1038/bjc.2015.248

Abstract | Full Text

Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study

Abhijit Sen, Konstantinos K Tsilidis, Naomi E Allen, Sabina Rinaldi, Paul N Appleby, Martin Almquist, Julie A Schmidt, Christina C Dahm, Kim Overvad, Anne Tjønneland, Agnetha L Rostgaard-Hansen, Françoise Clavel-Chapelon, Laura Baglietto, Marie-Christine Boutron-Ruault, Tilman Kühn, Verena A Katze, Heiner Boeing, Antonia Trichopoulou, Christos Tsironis, Pagona Lagiou, Domenico Palli, Valeria Pala, Salvatore Panico, Rosario Tumino, Paolo Vineis, HB(as) Bueno-de-Mesquita, Petra H Peeters, Anette Hjartåker, Eiliv Lund, Elisabete Weiderpass, J Ramón Quirós, Antonio Agudo, María- José Sánchez, Larraitz Arriola, Diana Gavrila, Aurelio Barricarte Gurrea, Ada Tosovic, Joakim Hennings, Maria Sandström, Isabelle Romieu, Pietro Ferrari, Raul Zamora-Ros, Kay-Tee Khaw, Nicholas J Wareham, Elio Riboli, Marc Gunter and Silvia Franceschi

Br J Cancer 2015 113: 840-847; advance online publication, August 27, 2015; 10.1038/bjc.2015.280

Abstract | Full Text

Is England closing the international gap in cancer survival?

Sarah Walters, Sara Benitez-Majano, Patrick Muller, Michel P Coleman, Claudia Allemani, John Butler, Mick Peake, Marianne Grønlie Guren, Bengt Glimelius, Stefan Bergström, Lars Påhlman and Bernard Rachet

Br J Cancer 2015 113: 848-860; advance online publication, August 4, 2015; 10.1038/bjc.2015.265

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: